IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v484y2012i7395d10.1038_nature10921.html
   My bibliography  Save this article

IFITM3 restricts the morbidity and mortality associated with influenza

Author

Listed:
  • Aaron R. Everitt

    (Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, UK)

  • Simon Clare

    (Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, UK)

  • Thomas Pertel

    (Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University)

  • Sinu P. John

    (Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University)

  • Rachael S. Wash

    (Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, UK)

  • Sarah E. Smith

    (Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, UK)

  • Christopher R. Chin

    (Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University)

  • Eric M. Feeley

    (Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University)

  • Jennifer S. Sims

    (Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University)

  • David J. Adams

    (Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, UK)

  • Helen M. Wise

    (Divison of Virology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QP, UK)

  • Leanne Kane

    (Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, UK)

  • David Goulding

    (Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, UK)

  • Paul Digard

    (Divison of Virology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QP, UK)

  • Verneri Anttila

    (Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, UK)

  • J. Kenneth Baillie

    (The Roslin Institute, University of Edinburgh, Roslin EH25 9RG, UK
    University of Edinburgh, Edinburgh EH16 4TJ, UK)

  • Tim S. Walsh

    (University of Edinburgh, Edinburgh EH16 4TJ, UK)

  • David A. Hume

    (The Roslin Institute, University of Edinburgh, Roslin EH25 9RG, UK)

  • Aarno Palotie

    (Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, UK)

  • Yali Xue

    (Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, UK)

  • Vincenza Colonna

    (Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, UK
    Institute of Genetics and Biophysics “A. Buzzati-Traverso”)

  • Chris Tyler-Smith

    (Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, UK)

  • Jake Dunning

    (Centre for Respiratory Infection, National Heart and Lung Institute, St Mary’s Campus, Imperial College London, W2 1PG, UK)

  • Stephen B. Gordon

    (Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK)

  • Rosalind L. Smyth

    (Institute of Translational Medicine, University of Liverpool, Alder Hey Children’s Hospital, Liverpool L12 2AP, UK)

  • Peter J. Openshaw

    (Centre for Respiratory Infection, National Heart and Lung Institute, St Mary’s Campus, Imperial College London, W2 1PG, UK)

  • Gordon Dougan

    (Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, UK)

  • Abraham L. Brass

    (Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University
    Gastrointestinal Unit, Massachusetts General Hospital)

  • Paul Kellam

    (Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, UK
    UCL/MRC Centre for Medical Molecular Virology, University College London, Cleveland Street, London W1T 4JF, UK)

Abstract

Interferon-inducible transmembrane (IFITM) protein 3 is shown to be an innate defence mechanism against viral infection in vivo; furthermore, a subset of the patients hospitalized during the H1N1 2009 pandemic carried a variant form of the IFITM3 gene.

Suggested Citation

  • Aaron R. Everitt & Simon Clare & Thomas Pertel & Sinu P. John & Rachael S. Wash & Sarah E. Smith & Christopher R. Chin & Eric M. Feeley & Jennifer S. Sims & David J. Adams & Helen M. Wise & Leanne Kan, 2012. "IFITM3 restricts the morbidity and mortality associated with influenza," Nature, Nature, vol. 484(7395), pages 519-523, April.
    • Handle: RePEc:nat:nature:v:484:y:2012:i:7395:d:10.1038_nature10921
    DOI: 10.1038/nature10921
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature10921
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/nature10921?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. M. Clement & J. L. Forbester & M. Marsden & P. Sabberwal & M. S. Sommerville & D. Wellington & S. Dimonte & S. Clare & K. Harcourt & Z. Yin & L. Nobre & R. Antrobus & B. Jin & M. Chen & S. Makvandi-Ne, 2022. "IFITM3 restricts virus-induced inflammatory cytokine production by limiting Nogo-B mediated TLR responses," Nature Communications, Nature, vol. 13(1), pages 1-16, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:484:y:2012:i:7395:d:10.1038_nature10921. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.